Navigation Links
Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO

nespimycin (KOS-953) is currently in Phase 1 and 2 clinical trials, primarily for multiple myeloma in combination with Velcade(R) (bortezomib) and HER2-positive metastatic breast cancer in combination with Herceptin(R) (trastuzumab). In addition, intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS-1022), are being evaluated in Phase 1 clinical trials.

Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's epothilone program is partnered with Roche through a global development and commercialization agreement.

For additional information on Kosan Biosciences, please visit the company's website at http://www.kosan.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include but are not limited to the further development and potential safety, efficacy, commercialization and other characteristics of Kosan's epothilone, KOS-1584[/R1645]; and initiations of clinical trials and the timing thereof. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of Kosan to differ materially from those indicated by these forward-looking statements, including, among others, risks related to the development of KOS-1584[/R1645], including the risk that studies may not demonstrate safety and efficacy sufficient to initiate clinical trials, continue clinical development, obtain the requisite regulatory approvals or to result in a marketable product; Kosan's dependence on its collaboration with Roche for develo
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:5/24/2013)... , May 24, 2013 ... administration for systemic delivery of therapeutic agents has been ... inhalation drug delivery showing significant promise. The crucial formulation ... a delivery device play a major role in the ... made in the development of new formulation techniques and ...
(Date:5/24/2013)... England and BOSTON , May ... drug discovery and development company, is pleased to announce that it ... Consultant to augment the Company,s business development capabilities in ... has more than 15 years of experience in business development, licensing ... Perlegen Sciences, Inc., Roche Pharma ( Japan ), Nippon ...
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated pharmaceutical company ... ("PRC"), today announced that it held its 2011 Annual ... 2011, in Harbin, PRC. At the Annual ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that China,s State ... Company,s real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene ... companion diagnostic test for the use of a targeted ...
Cached Medicine Technology:China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting 2China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug 2
(Date:5/24/2013)... Today marks the launch of Destination Halifax’s ... , The redesigned and enhanced Itinerary Builder will help ... their computer or mobile device that they can send, ... users to fill in their date of arrival and ... choice of vacation packages, accommodations, restaurants, and things to ...
(Date:5/24/2013)... Wixom, MI (PRWEB) May 24, 2013 ... recent Cute Baby Photo Contest. Lindsey Willis of Olathe, ... Cuties-brand diapers from DiaperBuys. Second prize was a ... Heather Tacher, North Las Vegas, Nev.; and third prize, ... Texas. , The contest was run through the company’s ...
(Date:5/24/2013)... London, UK (PRWEB) May 24, 2013 Wednesday, ... Duration: 60mins , Register to access webinar playback: ... every corner of the financial markets. Across the globe and ... will very probably affect M&A activity . For dealmakers, ... AIFM directive and the ‘Tobin Tax’ affects your corner of ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 ... of the latest update involving allegations that the ... SR (azithromycin) can allegedly cause potentially fatal ... reported on May 17, 2013* that Health Canada ... in warning that Zithromax can cause abnormal changes ...
(Date:5/24/2013)... Bridal Buy , a leading wedding dress online ... dresses are available in its wedding dresses 2013 ... fine fabrics, elegant beading, and exquisite embroidery. , ... eye for detailed designs. However, our lace spring wedding ... patterns and the hands of dressmakers,” said, Donnie Terry, ...
Breaking Medicine News(10 mins):Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:DiaperBuys.com Announces Photo Contest Winners 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
... risk, as did smoking, study found , , WEDNESDAY, May ... beer, may hasten the onset of pancreatic cancer, according ... Digestive Disease Week 2008 conference in San Diego. , ... liquor or wine in lowering the age of onset ...
... so sensitive that it can tell whether or not ... towards cancer development may revolutionize how future colonoscopies are ... Fla. , Investigators have found that technology known ... determine whether a colon polyp is benign (not precancerous) ...
... to Reduce Bureaucracy, Streamline Decision Making, INDIANAPOLIS, May ... today announced changes across its executive leadership,structure as the ... in,a challenging business environment., "Earlier this year I ... their respective areas to determine if they were optimally ...
... 21 As fast-food marketers launch,programs across the ... a time-pressured society -- one that is already ... is responding by extending an,innovative local health program ... the nation., Two years ago, the company ...
... May 21 The following is a,statement by Steve Case, ... of Senator Ted Kennedy,s brain cancer diagnosis:, "I was ... tumor.,Just two weeks ago I had the opportunity to testify ... redouble our nation,s efforts to fight,cancer, and was able to ...
... new study, patients are receiving estimated doses of radiation from ... that may be detrimental to their long term health, putting ... emergency physicians have not been made aware of the cumulative ... currently have no way to know or estimate any given ...
Cached Medicine News:Health News:Beer Drinking May Speed Pancreatic Cancer Onset 2Health News:Beer Drinking May Speed Pancreatic Cancer Onset 3Health News:Beer Drinking May Speed Pancreatic Cancer Onset 4Health News:Virtual biopsy can tell whether colon polyp is benign without removal, Mayo researchers say 2Health News:Lilly Announces Changes in Key Leadership Roles 2Health News:Lilly Announces Changes in Key Leadership Roles 3Health News:Lilly Announces Changes in Key Leadership Roles 4Health News:Lilly Announces Changes in Key Leadership Roles 5Health News:Capital BlueCross Goes National for Health 2Health News:Cumulative radiation exposure shows increased cancer risk for emergency department patients 2
Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Endotracheal Tube Stylet- Adult, Copper, Malleable, Non-Sterile, Latex Free, Suitable for tubes 5.0 mm I.D. or larger....
... Prevent dental and soft tissue damage. Used ... X-ray. Light-guided intubation is based upon the ... neck. This technique takes advantage of the ... the esophagus. A well-defined, circumscribed glow can ...
Medicine Products: